Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
Domain	Rap_GAP	SIPA1 SIPA1L2	3.50e-04	10	53	2	PF02145
Domain	Rap_GAP_dom	SIPA1 SIPA1L2	4.27e-04	11	53	2	IPR000331
Domain	RAPGAP	SIPA1 SIPA1L2	4.27e-04	11	53	2	PS50085
Domain	Cadherin_CS	FAT2 PCDHGB1 PCDHB8	3.66e-03	109	53	3	IPR020894
Domain	CADHERIN_1	FAT2 PCDHGB1 PCDHB8	4.05e-03	113	53	3	PS00232
Domain	Cadherin	FAT2 PCDHGB1 PCDHB8	4.05e-03	113	53	3	PF00028
Domain	CADHERIN_2	FAT2 PCDHGB1 PCDHB8	4.16e-03	114	53	3	PS50268
Domain	-	FAT2 PCDHGB1 PCDHB8	4.16e-03	114	53	3	2.60.40.60
Domain	CA	FAT2 PCDHGB1 PCDHB8	4.26e-03	115	53	3	SM00112
Domain	Cadherin-like	FAT2 PCDHGB1 PCDHB8	4.36e-03	116	53	3	IPR015919
Domain	Cadherin	FAT2 PCDHGB1 PCDHB8	4.58e-03	118	53	3	IPR002126
Domain	Cadherin_C	PCDHGB1 PCDHB8	6.33e-03	42	53	2	IPR032455
Domain	Cadherin_C_2	PCDHGB1 PCDHB8	6.33e-03	42	53	2	PF16492
Domain	C2	WWC3 SYT12 PLCG2	7.64e-03	142	53	3	PS50004
Domain	-	WWC3 SYT12 PLCG2	8.55e-03	148	53	3	2.60.40.150
Pubmed	BRCA2 interacts with the cytoskeletal linker protein plectin to form a complex controlling centrosome localization.	BRCA2 PLEC	2.46e-06	2	55	2	19709076
Pubmed	Functional proteomics mapping of a human signaling pathway.	TSKU ARHGAP5 PPP2R1A MYO6 ANAPC2 PDE4DIP PLCG2 PLEC	4.00e-06	591	55	8	15231748
Pubmed	Role of binding of plectin to the integrin beta4 subunit in the assembly of hemidesmosomes.	COL17A1 PLEC	1.47e-05	4	55	2	14668477
Pubmed	N-Terminomics for the Identification of In Vitro Substrates and Cleavage Site Specificity of the SARS-CoV-2 Main Protease.	DHX16 SORBS2 NUP98 PLEC SIPA1 SRRM2	2.23e-05	360	55	6	33111431
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	ARHGAP5 SORBS2 PTPRK CLIP2 MYO6 GUCY1B1 ASB3 PDE4DIP ABCC5 PLEC	2.94e-05	1285	55	10	35914814
Pubmed	Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.	FAM171A1 ARHGAP5 PPP2R1A PTPRK CLNS1A NAGLU NUP98 ZYG11B SRRM2	3.65e-05	1049	55	9	27880917
Pubmed	Junctional Epidermolysis Bullosa	COL17A1 PLEC	3.67e-05	6	55	2	20301304
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	DHX16 SORBS2 PDE4DIP ZYG11B SIPA1L2 SRRM2	4.42e-05	407	55	6	12693553
Pubmed	The N terminus of the transmembrane protein BP180 interacts with the N-terminal domain of BP230, thereby mediating keratin cytoskeleton anchorage to the cell surface at the site of the hemidesmosome.	COL17A1 PLEC	5.13e-05	7	55	2	10637308
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	ARHGAP5 NLGN3 PPP2R1A SORBS2 CLIP2 MYO6 PDE4DIP PLEC SIPA1 SIPA1L2	7.27e-05	1431	55	10	37142655
Pubmed	Analysis of the interactions between BP180, BP230, plectin and the integrin alpha6beta4 important for hemidesmosome assembly.	COL17A1 PLEC	8.78e-05	9	55	2	12482924
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	FAM171A1 NLGN3 PPP2R1A SORBS2 CLIP2 PDE4DIP SIPA1 UNC79	1.29e-04	963	55	8	28671696
Pubmed	A bead-based approach for large-scale identification of in vitro kinase substrates.	DHX16 CLNS1A NUP98 SRRM2	1.32e-04	163	55	4	22113938
Pubmed	Interaction of the bullous pemphigoid antigen 1 (BP230) and desmoplakin with intermediate filaments is mediated by distinct sequences within their COOH terminus.	COL17A1 PLEC	1.34e-04	11	55	2	12802069
Pubmed	The tetraspan molecule CD151, a novel constituent of hemidesmosomes, associates with the integrin alpha6beta4 and may regulate the spatial organization of hemidesmosomes.	COL17A1 PLEC	1.34e-04	11	55	2	10811835
Pubmed	Current insights into the formation and breakdown of hemidesmosomes.	COL17A1 PLEC	1.34e-04	11	55	2	16757171
Pubmed	Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms.	PPP2R1A MYO6 PDE4DIP NOL6 NAGLU NUP98 ZYG11B	1.80e-04	754	55	7	33060197
Pubmed	Efficient capture of cardiogenesis-associated genes expressed in ES cells.	SORBS2 EML2	1.89e-04	13	55	2	17286962
Pubmed	Cell cycle and adhesion defects in mice carrying a targeted deletion of the integrin beta4 cytoplasmic domain.	COL17A1 PLEC	1.89e-04	13	55	2	9670011
Pubmed	A striking organization of a large family of human neural cadherin-like cell adhesion genes.	FAT2 PCDHGB1 PCDHB8	2.07e-04	72	55	3	10380929
Pubmed	Phylogenetic analysis of the cadherin superfamily allows identification of six major subfamilies besides several solitary members.	FAT2 PCDHGB1 PCDHB8	2.52e-04	77	55	3	10835267
Pubmed	Large exons encoding multiple ectodomains are a characteristic feature of protocadherin genes.	FAT2 PCDHGB1 PCDHB8	2.82e-04	80	55	3	10716726
Pubmed	Phosphoproteome analysis of the human mitotic spindle.	NOL6 NUP98 PLEC SRRM2	3.46e-04	210	55	4	16565220
Pubmed	The TRIM9/TRIM67 neuronal interactome reveals novel activators of morphogenesis.	SORBS2 CLIP2 ZC3H12C SIPA1L2	3.99e-04	218	55	4	33378226
Pubmed	Hrd1-mediated ACLY ubiquitination alleviate NAFLD in db/db mice.	MYO6 PLEC	4.13e-04	19	55	2	32888949
Pubmed	Suppression of ACE2 SUMOylation protects against SARS-CoV-2 infection through TOLLIP-mediated selective autophagy.	DHX16 TRPM4 PPP2R1A MYO6 NUP98 SRRM2	5.16e-04	641	55	6	36057605
Pubmed	Use of expression data and the CGEMS genome-wide breast cancer association study to identify genes that may modify risk in BRCA1/2 mutation carriers.	BRCA2 PLCG2	5.56e-04	22	55	2	18095154
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	DHX16 PPP2R1A NOL6 NUP98 PLEC SRRM2	5.68e-04	653	55	6	22586326
Pubmed	Targeted proteomic analysis of 14-3-3 sigma, a p53 effector commonly silenced in cancer.	SORBS2 FAM117B SRRM2	5.75e-04	102	55	3	15778465
Pubmed	A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer.	NLGN3 MYO6	6.08e-04	23	55	2	25217961
Pubmed	Dynamic Protein Interactions of the Polycomb Repressive Complex 2 during Differentiation of Pluripotent Cells.	JARID2 PPP2R1A NOL6 NUP98 UNC79	8.72e-04	469	55	5	27634302
Pubmed	Large-scale mapping of human protein-protein interactions by mass spectrometry.	PPP2R1A MYO6 ASB3 NUP98 EML2 SRRM2 UNC79 CCNY	8.80e-04	1284	55	8	17353931
Pubmed	PINK1 Content in Mitochondria is Regulated by ER-Associated Degradation.	DHX16 PPP2R1A MYO6 PLEC SRRM2	9.40e-04	477	55	5	31300519
Pubmed	RNF138 inhibits late inflammatory gene transcription through degradation of SMARCC1 of the SWI/SNF complex.	PLEC SRRM2	9.70e-04	29	55	2	36800290
Pubmed	Defining the human deubiquitinating enzyme interaction landscape.	MYO6 CLNS1A NOL6 NUP98 ZYG11B PLEC SRRM2	9.99e-04	1005	55	7	19615732
Pubmed	The MYO6 interactome reveals adaptor complexes coordinating early endosome and cytoskeletal dynamics.	FAM171A1 MYO6 SRRM2	1.04e-03	125	55	3	29467281
Pubmed	E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins.	ARHGAP5 AFAP1L2 CLNS1A NAGLU FAM227B FAM186B	1.06e-03	736	55	6	29676528
Pubmed	Protein-protein interactions between large proteins: two-hybrid screening using a functionally classified library composed of long cDNAs.	DHX16 SORBS2 COL17A1	1.16e-03	130	55	3	12421765
Pubmed	Ligand-dependent differences in estrogen receptor beta-interacting proteins identified in lung adenocarcinoma cells corresponds to estrogenic responses.	MYO6 PLEC	1.18e-03	32	55	2	21951318
Pubmed	Cell Surface Proteomic Map of HIV Infection Reveals Antagonism of Amino Acid Metabolism by Vpu and Nef.	PTPRK PCDHGB1 CCR7	1.21e-03	132	55	3	26439863
Pubmed	New interaction partners for Nek4.1 and Nek4.2 isoforms: from the DNA damage response to RNA splicing.	MYO6 CLNS1A NUP98 SRRM2 FAM186B	1.30e-03	513	55	5	25798074
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	DHX16 SORBS2 NUP98 PLEC SRRM2 CCNY	1.37e-03	774	55	6	15302935
Pubmed	Proteomic analysis of the NOS2 interactome in human airway epithelial cells.	PPP2R1A CLNS1A PLEC	1.38e-03	138	55	3	23438482
Pubmed	ATPase-Modulated Stress Granules Contain a Diverse Proteome and Substructure.	PPP2R1A MYO6 NUP98 ZC3H7B	1.57e-03	315	55	4	26777405
Pubmed	Control of APC/C-dependent ubiquitin chain elongation by reversible phosphorylation.	PPP2R1A ANAPC2	1.58e-03	37	55	2	26811472
GeneFamily	Zinc fingers CCCH-type	ZC3H12C ZC3H7B	2.20e-03	35	36	2	73
GeneFamily	Clustered protocadherins	PCDHGB1 PCDHB8	7.19e-03	64	36	2	20
ToppCell	LPS-IL1RA-Endothelial-Endothelial-Activated_Alv_Cap\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FAM171A1 MYO6 FAM117B ZC3H12C SIPA1L2	3.68e-06	193	54	5	a3636c35ed25aabe2f1aba016c9fe125327bbfaf
ToppCell	(02)_MMP9/10+-(1)_GFP\|(02)_MMP9/10+ / shred by cell type by condition	JARID2 PPP2R1A COL17A1 PTPRK PLEC	4.27e-06	199	54	5	448ba982be804007f991d469eca9d885b21ae499
ToppCell	LPS_only-Endothelial-Endothelial-Alv_Cap\|LPS_only / Treatment groups by lineage, cell group, cell type	FAM171A1 MYO6 GUCY1B1 ZC3H12C CCNY	4.37e-06	200	54	5	432384faeade8e609154fab3d96c955a8ec868dd
ToppCell	NS-control\|NS / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	ARHGAP5 FAT2 SORBS2 PTPRK MYO6	4.37e-06	200	54	5	ecbe89ff95d046155b984c8c150e0b9e7278f839
ToppCell	LPS_only-Endothelial-Endothelial-Alv_Gen_Intermediate\|LPS_only / Treatment groups by lineage, cell group, cell type	FAM171A1 MYO6 GUCY1B1 SIPA1L2 CCNY	4.37e-06	200	54	5	b1fadb2b5e37e0f51e079d8409c2647eef68dc3b
ToppCell	LPS_IL1RA-Endothelial-Endothelial-Activated_Alv_Cap\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	MYO6 GUCY1B1 ZC3H12C SIPA1L2 CCNY	4.37e-06	200	54	5	79e51afb57ca38aacebd0298e5e727b55c0cfff9
ToppCell	Children_(3_yrs)-Endothelial-endothelial_cell_of_artery-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	FAM171A1 SORBS2 AFAP1L2 PLCG2	5.49e-05	171	54	4	1597459c971d6befa991d59dc66b41b6a522f797
ToppCell	LPS-IL1RA-Endothelial-Endothelial-Alv_Cap\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MYO6 FAM117B ZC3H12C SIPA1L2	6.70e-05	180	54	4	544fb373a3346186ec60afe2cfcf141bb04a1eed
ToppCell	droplet-Limb_Muscle-MUSCLE-1m-Macroglial-unknown\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NLGN3 SORBS2 AFAP1L2 UNC79	7.00e-05	182	54	4	82ca6d5ed48b4c487ce00b9309255abb8f20b61d
ToppCell	facs-Lung-24m-Hematologic-myeloid-non-classical_monocyte-nonclassical_monocyte_l14\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	COL17A1 PRRG3 PLCG2 SIPA1L2	7.15e-05	183	54	4	6e5b39c0170d62eb7fdd411dcfff51ed176573d0
ToppCell	PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD8_c01-LEF1\|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k)	PTPRK PRRG3 FAM117B CCR7	7.45e-05	185	54	4	fcd95bc074e982fc7b8fd48d2e80038b9ea35ebb
ToppCell	LPS-IL1RA+antiTNF-Endothelial-Endothelial-Activated_Alv_Cap\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FAM171A1 WWC3 MYO6 ZC3H12C	7.77e-05	187	54	4	f3397dbc23b6c2f24e2c1ba887d8f9aef3ee01a1
ToppCell	LPS-IL1RA+antiTNF-Endothelial-Endothelial-Alv_Cap\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FAM171A1 MYO6 ZC3H12C SIPA1L2	7.93e-05	188	54	4	73f6ec915934154f435a376cb274b058ff7c5f35
ToppCell	LPS_only-Endothelial-Endothelial-Activated_Alv_Cap\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FAM171A1 PTPRK MYO6 ZC3H12C	8.43e-05	191	54	4	a7b18bcf27c38ad2353c239ecb309c80f3ef3359
ToppCell	LPS-antiTNF-Endothelial-Endothelial-Activated_Alv_Cap\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FAM171A1 MYO6 FAM117B ZC3H12C	8.60e-05	192	54	4	c618ede75dce3988c87a5b8f98d8e94e1dd66efd
ToppCell	LPS-IL1RA-Endothelial-Endothelial\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FAM171A1 MYO6 ZC3H12C SIPA1L2	8.95e-05	194	54	4	1d39d968730a7e85b6161c1c8a6bd38afe9bcad7
ToppCell	LPS-IL1RA-Endothelial\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FAM171A1 MYO6 ZC3H12C SIPA1L2	8.95e-05	194	54	4	43f92b0533e26633dc94cce554045d641ef8fd76
ToppCell	367C-Epithelial_cells-Epithelial-H_(AT1)\|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)	TSKU FAT2 COL17A1 SIPA1	9.32e-05	196	54	4	e8db58e82300981f981402618a1befb91f6690fd
ToppCell	367C-Epithelial_cells-Epithelial-H_(AT1)-\|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)	TSKU FAT2 COL17A1 SIPA1	9.32e-05	196	54	4	2cf42b702ea15adfa6bbd86a3c9613271863f86c
ToppCell	LPS_IL1RA-Endothelial-Endothelial-Alv_Cap\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	MYO6 FAM117B PLEC CCNY	1.01e-04	200	54	4	7034f57e282982c19c13ee8ab78eabaffa069e30
ToppCell	LPS_IL1RA-Endothelial-Endothelial-Alv_Gen_Intermediate\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	FAM171A1 MYO6 PLEC CCNY	1.01e-04	200	54	4	b70b7adb7c187e6253c7f0bb4c1f09c85ef7142c
ToppCell	control\|World / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	ARHGAP5 FAT2 SORBS2 MYO6	1.01e-04	200	54	4	97f36d2c197e03d93a1fc59949d77ae90f6e6a9a
ToppCell	Control_saline-Endothelial\|Control_saline / Treatment groups by lineage, cell group, cell type	FAM171A1 MYO6 PLEC SIPA1L2	1.01e-04	200	54	4	3372c488a39fe812fa94e4f0564594186fea3db5
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW09-Neuronal-Interneuron\|GW09 / Sample Type, Dataset, Time_group, and Cell type.	AFAP1L2 PRRG3 TMPRSS7 UNC79	1.01e-04	200	54	4	a6500d0d2e8bcac92381ab771dbdee66b0e1d48e
ToppCell	LPS_IL1RA_TNF-Endothelial-Endothelial-Activated_Alv_Cap\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	WWC3 MYO6 GUCY1B1 CCNY	1.01e-04	200	54	4	89821a264e872ed53e08e9d3609d5cc5c314503e
ToppCell	Control_saline-Endothelial-Endothelial\|Control_saline / Treatment groups by lineage, cell group, cell type	FAM171A1 MYO6 PLEC SIPA1L2	1.01e-04	200	54	4	e77eba6172cabf85b8028638ed35299f2f079cd8
Disease	melanoma	BRCA2 PTPRK CLNS1A PCDHB8 SIPA1	6.90e-05	248	51	5	C0025202
Disease	HMG CoA reductase inhibitor use measurement	BRCA2 GUCY1B1 FAM117B PLEC	3.22e-04	189	51	4	EFO_0009932
Disease	lymphocyte count	JARID2 SYT12 PCDHGB1 ASB3 OSER1 ABCC5 CCR7 PLEC ZC3H7B	8.20e-04	1464	51	9	EFO_0004587
Disease	uterine fibroid measurement	SORBS2 PTPRK	1.15e-03	29	51	2	EFO_0009410

Protein segments in the cluster

Peptide	Gene	Start	Entry
RTRSELLPFLTDTIY	PPP2R1A	46	P30153
SLLSLDYAELSSRIL	COL17A1	1121	Q9UMD9
RAYTLPISKEESRLS	FAM227B	351	Q96M60
GLLESRLDPYLRSLE	ANAPC2	116	Q9UJX6
SLEPVERSLETSSYL	AFAP1L2	346	Q8N4X5
IPELLYSDLQRSSSE	CCR7	191	P32248
RYSLIDRSSAPELLR	CLIP2	971	Q9UDT6
SRLESYRPDTDLSRE	CCNY	21	Q8ND76
LSEESELRLPHYLRS	FAM186B	676	Q8IYM0
LLREFLSEPDLASYS	DHX16	501	O60231
ATSPAFRYDLLDLTR	NAGLU	551	P54802
EPRSITADPLDYRLS	NUP98	1511	P52948
RRALRLPENTSYSDL	FAM171A1	151	Q5VUB5
LTLSYSRRGDLEISL	PCSK4	496	Q6UW60
PDSRDTSRLEYLILS	FAT2	2406	Q9NYQ8
SILASDLEPRELLSY	PCDHGB1	486	Q9Y5G3
YETLRERSSLLPRLD	NOL6	711	Q9H6R4
DDLTRRGLYLSDIPL	GUCY1B1	331	Q02153
LRSESSPEAYIRCLR	PLCG2	336	P16885
LLTLYRDQDRESPST	PLEKHG6	526	Q3KR16
SDRSIYILDDPLSAL	ABCC5	701	O15440
DYTLTLRRSPDDIPL	NLGN3	791	Q9NZ94
SERLRSDSYISQLPL	ASB3	476	Q9Y575
LALPLYRSTRRLSEE	C17orf99	231	Q6UX52
LEYPTISLHALSRDR	CLNS1A	56	P54105
TAPTSSEDYLRLKRR	BRCA2	3371	P51587
RRTSSLDTLAAPYLA	FAM117B	216	Q6P1L5
DIPLDRLTISYCRSS	MRPL58	71	Q14197
TDRLGERDPRSLTLY	MAN2C1	131	Q9NTJ4
DELAPTYSLDTRSEL	EML2	36	O95834
TYSLDTRSELPSCRL	EML2	41	O95834
PRLTLYSEAELSSLV	ERVFC1	361	P60507
ATAESSRLLDVPRYL	PTPRK	836	Q15262
LSYDSLSPEEHRRLE	JARID2	706	Q92833
FYTLLTETPLDRESR	PCDHB8	401	Q9UN66
SLVYLRPRSSTSEDE	OR10Q1	261	Q8NGQ4
EILLSLSYLPTAERL	SYT12	286	Q8IV01
PIDSLRDSRSLSYSP	SRRM2	2681	Q9UQ35
PDSLFRSLLERYLTA	TDRD6	201	O60522
NLSPRRSLYRTLSDE	SIPA1L2	1476	Q9P2F8
FSELYTLSLQEPSRR	SIPA1	771	Q96FS4
LPTPSDRSRYRLDLE	ARHGAP5	1001	Q13017
LAPERRSTLEDYSQS	OSER1	226	Q9NX31
ERPASLYQSSIDRSL	SORBS2	226	O94875
LTLSLEDPYERCFSR	ZYG11B	146	Q9C0D3
TDSLTIYDSLLPIRS	TMPRSS7	301	Q7RTY8
PSTDERLSYTQLLRR	PLEC	3986	Q15149
SPERRFSLDTDYRIS	ZC3H12C	606	Q9C0D7
PTAFSRLRYLESLDL	TSKU	101	Q8WUA8
LESTLYLPELSLSRL	PRRG3	171	Q9BZD7
LRLSDRTDPAAVYSL	TRPM4	91	Q8TD43
RLYRSDSDSSTLPRK	WWC3	921	Q9ULE0
RSLLYSVLRDAPSER	UNC79	96	Q9P2D8
LLPYSETRLDALDSF	ZC3H7B	351	Q9UGR2
DLALRRSLDSYPVSK	MYO6	1031	Q9UM54
SDYSSSLERPRKLRA	PDE4DIP	1386	Q5VU43